Parathyroid Adenoma Surgery in Corpus Christi, TX
A parathyroid adenoma is a benign, autonomous tumor of one of the four parathyroid glands that produces excessive amounts of parathyroid hormone (PTH) independent of physiologic calcium feedback. Parathyroid adenomas are the cause of primary hyperparathyroidism in approximately 85 to 90 percent of cases and are the most surgically curable form of endocrine disease. At Corpus Christi ENT Sinus & Allergy, Dr. Todd M. Weiss performs minimally invasive parathyroidectomy (MIP) for parathyroid adenoma with a cure rate exceeding 95 percent.
Why Surgery Is the Treatment of Choice
Parathyroid adenoma surgery (parathyroidectomy) is the only definitive, curative treatment for primary hyperparathyroidism caused by a parathyroid adenoma. Medical management with calcimimetics (cinacalcet) or bisphosphonates can partially control biochemical parameters but does not remove the adenoma, does not normalize PTH, and requires indefinite medication use. Surgery, by contrast, provides permanent cure in the vast majority of cases with a low complication rate in experienced hands.
Indications for Surgery
Current international guidelines (the Fourth International Workshop on Asymptomatic Primary Hyperparathyroidism) recommend surgery for:
- Symptomatic primary hyperparathyroidism (kidney stones, osteoporosis, neuromuscular symptoms)
- Serum calcium greater than one milligram per deciliter above the upper limit of normal
- Creatinine clearance less than 60 mL/min
- T-score of minus 2.5 or lower at any skeletal site on DEXA scan
- Age below 50 years
- Patient preference for surgery after informed discussion
Many physicians and patients also elect surgery for asymptomatic disease based on quality-of-life considerations, as prospective studies demonstrate neuropsychological and quality-of-life improvements following successful parathyroidectomy even in patients who were classified as asymptomatic at baseline.
Preoperative Localization
Accurate preoperative localization of the adenoma is essential for minimally invasive surgery. Standard localization workup includes:
- Sestamibi parathyroid scan (Tc-99m sestamibi scintigraphy): a nuclear medicine study with high sensitivity for single-gland adenoma; often combined with SPECT-CT for three-dimensional localization
- Neck ultrasound: identifies enlarged parathyroid glands posterior or inferior to the thyroid gland; operator-dependent sensitivity
- 4D CT scan of the neck: provides detailed anatomical localization and is particularly useful for ectopic adenomas (glands located in the mediastinum, retroesophageal space, or within the thyroid gland)
When two concordant localization studies agree on the site of the adenoma, minimally invasive parathyroidectomy can be performed with confidence. When studies are discordant or negative, bilateral neck exploration with visualization of all four parathyroid glands may be required.
Minimally Invasive Parathyroidectomy (MIP)
MIP is performed under general anesthesia through a focused, two- to three-centimeter neck incision directed at the preoperatively localized adenoma. The recurrent laryngeal nerve is identified and protected. The adenoma is identified, isolated, and excised.
Intraoperative PTH monitoring (Miami criterion) is used to confirm successful removal: a drop in PTH of greater than 50 percent from the pre-excision baseline, to within the normal range, within 10 minutes of adenoma removal confirms that all hyperfunctioning tissue has been excised and that the procedure is complete. This real-time biochemical feedback allows the surgeon to confirm cure at the time of surgery, avoiding unnecessary exploration of additional glands.
Recovery
- Day of surgery: outpatient procedure; discharged to home after recovery from anesthesia
- Days 1 to 3: mild neck soreness at the incision site; soft diet initially; calcium and vitamin D supplementation is prescribed post-operatively
- Week 1: most patients return to light activity within one week; incision care with silicone gel or strips to optimize scar cosmesis
- Week 1 to 2: post-operative laboratory testing (serum calcium and PTH) confirms biochemical cure
- Weeks 2 to 4: return to full activity; serum calcium normalizes progressively as the previously suppressed normal parathyroid glands resume function
Outcomes
Minimally invasive parathyroidectomy guided by preoperative localization and intraoperative PTH monitoring achieves cure defined as normocalcemia in greater than 95 percent of patients with single-gland adenoma. Post-operative hypocalcemia, from temporary suppression of the remaining normal parathyroid glands, is the most common complication and is managed with calcium and vitamin D supplementation. Permanent hypoparathyroidism is rare following single-gland surgery. Recurrent laryngeal nerve injury is uncommon but may cause hoarseness; this risk is discussed during the pre-operative consultation.
Schedule an Appointment Today
If you’ve been diagnosed with primary hyperparathyroidism, minimally invasive surgery offers a lasting cure. Call us at (361) 320-6130 or connect with us online to schedule a consultation.